NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norethindrone And Ethinyl Estradiol (7/14), and what generic alternatives are available?
Norethindrone And Ethinyl Estradiol (7/14) is a drug marketed by Watson Labs Teva and Watson Labs and is included in two NDAs.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)?
- What are the global sales for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)?
- What is Average Wholesale Price for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)?
Summary for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Clinical Trials: | 41 |
Patent Applications: | 131 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) at DailyMed |
![NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) drug patent expirations Drug patent expirations by year for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)](/p/graph/s/t/NORETHINDRONE_AND_ETHINYL_ESTRADIOL_(7/14)-patent-expirations.png)
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | Early Phase 1 |
Celerion | Phase 1 |
Achillion, a wholly owned subsidiary of Alexion | Phase 1 |
See all NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) clinical trials
US Patents and Regulatory Information for NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Teva | NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 071041-001 | Sep 24, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 071042-001 | Sep 24, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |